RUNX1 and central nervous system cancer: RUNX1 and RUNX2 upregulate LGALS3 (galectin-3) [42], a protein which suppresses anoikis and drug-induced apoptosis [43] and whose expression is correlated with metastasis in osteosarcoma [44] and progression in glioma [45].